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Biophysical Journal Volume 100 April 2011 2075 2075Comments to the EditorThe Lipidic Cubic Phase as a Membrane MimeticSeparovic et al. (1), in commenting on our recent Letter (2),
state that ‘‘.the main point of this Biophysical Letter.that
the ‘in meso’ approach is a physiologically relevant environ-
ment, is misleading.’’.
The thrust of the work described in the Letter was to test
the hypothesis that the inherent flexibility of the hosting
mesophase under trial conditions would enable the in
meso crystallization of a small membrane protein. By
‘‘small’’, we were referring to integral proteins or peptides
with four or fewer transmembrane crossings. Linear grami-
cidin was chosen as the model small protein with which to
perform the test. The fact that gramicidin was reported to
assume different conformations made it an appealing model
system. One of the objectives of the study therefore was to
determine whether it would crystallize in any form by the in
meso method. And it did. This result was considered signif-
icant because it meant that the method might now be
brought to bear on other integral membrane peptides that
abound in Nature. We fail to see how this result is
misleading.
The work described in the Letter led to hypotheses since
investigated (3). This and the obvious issues that the results
raise, which could not be addressed in the Letter for lack of
space, are discussed in detail in the article by Ho¨fer et al. (3).
There, mechanisms are presented for how crystallization of
the double-stranded form of gramicidin might come about
under in meso conditions. Tracking the peptide’s conforma-
tion through sample preparation on to crystal growth isSubmitted December 16, 2010, and accepted for publication February 25,
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0006-3495/11/04/2075/1 $2.00needed to establish exactly how a particular form ends up
in the final crystal.
We remain convinced that the bicontinuous lipidic meso-
phase, with which in meso crystallogenesis is done, is a reli-
able membrane mimetic (4,5). As always, solved structures
must be evaluated for biological relevance by whatever
means possible.
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